Literature DB >> 23204478

The benefit of population-based studies for older patients with acute myeloid leukemia.

Ulrike Bacher, Torsten Haferlach.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23204478      PMCID： PMC3590082          DOI： 10.3324/haematol.2012.080242

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Dependence of age-specific incidence of acute myeloid leukemia on karyotype.

Authors:  C Schoch; W Kern; P Krawitz; M Dugas; S Schnittger; T Haferlach; W Hiddemann
Journal:  Blood       Date:  2001-12-01       Impact factor: 22.113

Review 2.  Reduced intensity conditioning (RIC) haematopoietic cell transplants in elderly patients with AML.

Authors:  Dietger Niederwieser; Thoralf Lange; Michael Cross; Nadesda Basara; Haifa Al-Ali
Journal:  Best Pract Res Clin Haematol       Date:  2006       Impact factor: 3.020

3.  Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival.

Authors:  G Juliusson; R Billström; A Gruber; E Hellström-Lindberg; M Höglunds; K Karlsson; D Stockelberg; A Wahlin; M Aström; C Arnesson; U Brunell-Abrahamsson; J Carstensen; E Fredriksson; E Holmberg; K Nordenskjöld; F Wiklund
Journal:  Leukemia       Date:  2006-01       Impact factor: 11.528

4.  "I am older, not elderly," said the patient with acute myeloid leukemia.

Authors:  Charles A Schiffer
Journal:  J Clin Oncol       Date:  2009-12-21       Impact factor: 44.544

5.  Acute myeloid leukemia in the real world: why population-based registries are needed.

Authors:  Gunnar Juliusson; Vladimir Lazarevic; Ann-Sofi Hörstedt; Oskar Hagberg; Martin Höglund
Journal:  Blood       Date:  2012-03-01       Impact factor: 22.113

6.  Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia.

Authors:  Pierre Fenaux; Ghulam J Mufti; Eva Hellström-Lindberg; Valeria Santini; Norbert Gattermann; Ulrich Germing; Guillermo Sanz; Alan F List; Steven Gore; John F Seymour; Hervé Dombret; Jay Backstrom; Linda Zimmerman; David McKenzie; C L Beach; Lewis R Silverman
Journal:  J Clin Oncol       Date:  2009-12-21       Impact factor: 44.544

7.  Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes.

Authors:  Utz Krug; Christoph Röllig; Anja Koschmieder; Achim Heinecke; Maria Cristina Sauerland; Markus Schaich; Christian Thiede; Michael Kramer; Jan Braess; Karsten Spiekermann; Torsten Haferlach; Claudia Haferlach; Steffen Koschmieder; Christian Rohde; Hubert Serve; Bernhard Wörmann; Wolfgang Hiddemann; Gerhard Ehninger; Wolfgang E Berdel; Thomas Büchner; Carsten Müller-Tidow
Journal:  Lancet       Date:  2010-12-03       Impact factor: 79.321

8.  Age and acute myeloid leukemia.

Authors:  Frederick R Appelbaum; Holly Gundacker; David R Head; Marilyn L Slovak; Cheryl L Willman; John E Godwin; Jeanne E Anderson; Stephen H Petersdorf
Journal:  Blood       Date:  2006-02-02       Impact factor: 22.113

9.  Non-intensive treatment with low-dose 5-aza-2'-deoxycytidine (DAC) prior to allogeneic blood SCT of older MDS/AML patients.

Authors:  M Lübbert; H Bertz; B Rüter; R Marks; R Claus; R Wäsch; J Finke
Journal:  Bone Marrow Transplant       Date:  2009-04-13       Impact factor: 5.483

10.  Survival of elderly patients with acute myeloid leukemia.

Authors:  Alessandro Pulsoni; Livio Pagano; Roberto Latagliata; Marco Casini; Raffaella Cerri; Monica Crugnola; Lorella De Paoli; Eros Di Bona; Rosangela Invernizzi; Filippo Marmont; Maria Concetta Petti; Gianmatteo Rigolin; Francesca Ronco; Antonio Spadano; Maria Elena Tosti; Giuseppe Visani; Alfonso Mele; Franco Mandelli
Journal:  Haematologica       Date:  2004-03       Impact factor: 9.941
View more
  1 in total

1.  Comorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study.

Authors:  L S G Østgård; J M Nørgaard; H Sengeløv; M Severinsen; L S Friis; C W Marcher; I H Dufva; M Nørgaard
Journal:  Leukemia       Date:  2014-08-05       Impact factor: 11.528
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.